LTGO Latigo Biotherapeutics, Inc.
Nasdaq · CIK 2056611 · Pharmaceutical Preparations
Public articles
No public articles yet. Follow LTGO to track filings and write notes.
Recent filings
No filings match the current filters.
| Form | Filed | Title | Accession |
|---|---|---|---|
| 10-Q | 2026-09-03 | 10-Q | 0001193125-26-381969 |
| 8-K | 2026-09-03 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | 0001193125-26-381912 |
| SCHEDULE 13G | 2026-08-18 | — | 0001193125-26-355798 |
| SCHEDULE 13D | 2026-08-17 | — | 0001104659-26-097980 |
| SCHEDULE 13G | 2026-08-17 | — | 0001346824-26-000233 |
| SCHEDULE 13G | 2026-08-13 | — | 0001172661-26-003404 |
| 3 | 2026-08-12 | 3 | 0001193125-26-345811 |
| S-8 | 2026-08-10 | S-8 | 0001193125-26-342582 |
| 8-K | 2026-08-10 | 5.03 Amendments to Articles of Incorporation or Bylaws · 8.01 Other Events · 9.01 Financial Statements and Exhibits | 0001193125-26-342321 |
| 424B4 | 2026-08-07 | 424B4 | 0001193125-26-340329 |
| EFFECT | 2026-08-06 | — | 9999999995-26-002566 |
| 3 | 2026-08-06 | OWNERSHIP DOCUMENT | 0001104659-26-092247 |
| 3 | 2026-08-06 | — | 0001231919-26-000841 |
| 3 | 2026-08-06 | OWNERSHIP DOCUMENT | 0001104659-26-092240 |
| 3 | 2026-08-06 | — | 0002144246-26-000002 |
| 3 | 2026-08-06 | — | 0001349376-26-000006 |
| 3 | 2026-08-06 | — | 0001866171-26-000002 |
| 3 | 2026-08-06 | — | 0001523672-26-000006 |
| 3 | 2026-08-06 | — | 0001604019-26-000012 |
| 3 | 2026-08-06 | — | 0002143741-26-000002 |